Global Buergear’s Disease Treatment Market, By Diagnosis Type (Blood Test, Allens’ Test, Angiogram, Tissue Biopsy and Others), Treatment (Medication, Surgery and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2030.
Buerger’s Disease Treatment Market Analysis and Size
Developing economies are major markets for Buerger’s disease treatment because of the expansion of healthcare infrastructure in these economies. Major market players operating in the market are focused on expansion of their product portfolios by emerging new products with reduced side-effects and enhanced effectiveness to treat Buerger’s disease. Economic development, increased disposable income of patients, and healthcare awareness in Asia and Latin America are slowly attracting major players to expand their business in these regions.
Data Bridge Market Research analyses a growth rate in the buerger’s disease treatment market in the forecast period 2023-2030. The expected CAGR of buerger’s disease treatment market is tend to be around 5.50% in the mentioned forecast period. The market was valued at USD 390.95 million in 2022, and it would grow upto USD 600 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Buerger’s Disease Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnosis Type (Blood Test, Allens’ Test, Angiogram, Tissue Biopsy and Others), Treatment (Medication, Surgery and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
FUJIFILM Holdings Corporation (Japan), General Electric (US), Koninklijke Philips N.V. (Netherlands), Pluristem Inc. (Israel), Shimadzu Corporation (Japan), Siemens Healthcare GmbH (Germany), STEMPEUTICS RESEARCH PVT LTD. (India), Toshiba Medical Corporation (Japan), t2cure GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Buerger’s disease is a genetic condition which often affects young or middle-aged male smokers. This is typically characterized by narrowing or obstruction of the extremities' veins and arteries, that leads to a decreased blood supply to these areas as peripheral vascular disease. The exact causes of this disease are not really known but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of this disease are pain in feet and arms, inflammation, Raynaud's phenomenon and such. There is no 100% cure for this disease.
Global Buerger’s Disease Treatment Market Dynamics
Drivers
- High Prevalence of Cigarette Smoking and Its Associated Therapy
Tobacco abuse treatment providers and manufacturers of treatment products are primarily focused on the creation of awareness among people and drug store owners about the severe effects of tobacco in order to expand their customer pool. For instance, cigarette smoking is a major cause of Buerger’s disease. Increasing awareness about these health hazards has prompted patients to choose smoking cessation therapy. Additionally. smoking cessation campaigns have also proved to be a major driver of the global buerger’s disease treatment market.
- Growing advancements in biologics
All contributing factors are the advances in advanced biologics, increased purchasing power, increased healthcare expenditure, and worldwide access to high-quality medications for middle- and poor-class families. On the other hand, the global buerger’s disease treatment market is predicted to increase quickly because of the enhanced treatment regarding early treatment and screening of buerger’s disease treatment and shift the market outlook. Consequently, growing advancements in biologics is creating huge opportunities for the growth of global buerger’s disease treatment market.
Opportunities
- Increase in Diagnostic Tests
There are varied diagnostic tests that are helping in increasing the growth of the market. Several tests such as Allen’s test, angiogram, tissue biopsy are contributing for the same. Rise in the number of blood tests for the diagnosis of Buerger’s disease is anticipated to expand the market growth. Furthermore, blood test is the primary test that a physician suggest to rule out the Buerger’s disease. This creates much opportunities for the market growth.
- Increased Clinical Research
Approvals for new treatments or therapies plays a major role in the growth of this market. For instance, in 2016, the Indian company named STEMPEUTICS RESEARCH PVT LTD got limited approval from the Drugs Controller General (India) for commercialization of stem cell based biological product Stempeucel for the treatment of Buerger's Disease. Additionally, Germany based company named t2cure GmbH also initiated a pivotal clinical study for Buerger's disease. Thus, all these factors create much opportunities for the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified healthcare professionals who are unable to perform the treatments could reduce the growth of the buerger’s disease treatment market over a forecast period.
- Low Awareness About Addiction Programs
Low awareness about addiction treatment products as well as awareness programs in developing countries is projected to restrain the market during the forecast period.
This buerger’s disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the buerger’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Buerger’s Disease Treatment Market Scope
The buerger’s disease treatment market is segmented on the basis of diagnosis type, treatment, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis Type
- Blood Test
- Allens’ Test
- Angiogram
- CT
- MRI
- X-Ray
- Others
- Tissue Biopsy
- Others
Treatment
- Medication
- Surgery
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Buerger’s Disease Treatment Market Regional Analysis/Insights
The buerger’s disease treatment market is analyzed and market size insights and trends are provided by diagnosis, treatment, end-user and distribution channel as referenced above.
The major countries covered in the buerger’s disease treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to the availability of funding for research and clinical trials.
Asia-Pacific is expected to account for the largest market share due to several significant factors such as the expansion of healthcare facilities and government support to enhance public health in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Buerger’s Disease Treatment Market Share Analysis
The buerger’s disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to buerger’s disease treatment market
Key players operating in the buerger’s disease treatment market include:
- FUJIFILM Holdings Corporation (Japan)
- General Electric (US)
- Koninklijke Philips N.V. (Netherlands)
- Pluristem Inc. (Israel)
- Shimadzu Corporation (Japan)
- Siemens Healthcare GmbH (Germany)
- STEMPEUTICS RESEARCH PVT LTD. (India)
- Toshiba Medical Corporation (Japan)
- t2cure GmbH (Germany))
SKU-